Showing results (61-70 of 107) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Differential expression of nuclear retinoid receptors in normal and malignant prostatesY Lotan, X C Xu, M Shalev, et al.Cancer|January 15, 1998
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgeryA M Stapleton, P Zbell, M W Kattan, et al.Human Pathology|August 3, 2000
Cytopathic effect of in situ gene therapy in prostate cancerG Ayala, T M Wheeler, M Shalev, et al.Cancer|January 15, 1995
The frequency of apoptosis correlates with the prognosis of Gleason Grade 3 adenocarcinoma of the prostateM Aihara, P T Scardino, L D Truong, et al.Oncogene|August 5, 2000
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosisT L Timme, A Goltsov, S Tahir, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1995
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancerJ A Eastham, L D Truong, E Rogers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clustered p53 immunostaining: a novel pattern associated with prostate cancer progressionG Yang, A M Stapleton, T M Wheeler, et al.Cancer Surveys|January 1, 1991
Experimental oncogene induced prostate cancerT C Thompson, D Kadmon, T L Timme, et al.Cancer Gene Therapy|July 14, 2007
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancerH Wang, G Yang, T L Timme, et al.Journal of the National Cancer Institute|July 5, 2001
Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox virusesT S Griffith, M Kawakita, J Tian, et al.Pageof 11